首页 > 最新文献

Hellenic Journal of Cardiology最新文献

英文 中文
Modifiers of the Association between E/e' Ratio and Survival among Patients with No Apparent Structural or Functional Cardiac Abnormality 无明显心脏结构或功能异常受试者的 E/e' 比值与存活率之间关系的调节因素
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-01 DOI: 10.1016/j.hjc.2024.01.005
Yishay Wasserstrum , Rami Gilead , Sagit Ben-Zekry , Efrat Mazor-Dray , Anan Younis , Amit Segev , Elad Maor , Rafael Kuperstein

Background

The ratio between early mitral flow wave to early diastolic mitral annulus velocity (E/e’ ratio) varies according to age and sex and is associated with mortality in heart failure. We sought to describe the association between E/e’ and mortality in patients with no apparent structural or functional cardiac abnormality and explore possible modifiers of this association.

Methods

A retrospective study of 104,315 patients who underwent echocardiographic evaluation during 2009-2021 in the largest tertiary center in Israel. Patients with cancer, ventricular dysfunction, significant valvular or structural heart disease, or evidence of pulmonary hypertension were excluded.

Results

The final analysis included 32,836 patients with a median age of 56 (43-66) years, and 13,547 (41%) were female. The median E/e’ was 8.3 (6.8-10.3), and 9,306 (28%) had an E/e’ >10. During a median follow-up of 5.7 (3.3-8.5) years, 2,396 (7.3%) individuals died. E/e’ >10 was associated with mortality (adjusted hazard ratio [HR] 1.16, 95% confidence interval [CI] 1.07-1.27, p<0.001). The mortality risk associated with E/e’ >10 was significantly higher in those aged ≤70 (HR 1.26, 95% CI 1.12-1.42, p<0.001), males (HR 1.34, 95% CI 1.19-1.49, p<0.001), a normal left ventricular mass (HR 1.13, 95% CI 1.02-1.24, p = 0.017), and pulmonary artery pressure <30 mmHg (HR 1.18, 95% CI 1.06-1.30, p = 0.003).

Conclusion

An elevated E/e’ is associated with mortality, specifically in younger individuals, males, and those with a normal left ventricular mass and lower pulmonary artery pressure. This suggests that an elevated E/e’ might be a marker of subclinical risk in these subgroups. Further studies are needed to identify whether an elevated E/e' is useful in shared decision-making regarding the management of cardiovascular risk factors.
背景E/e'比值因年龄和性别而异,与心力衰竭患者的死亡率有关。我们试图描述E/e'与无明显心脏结构或功能异常者死亡率之间的关系,并探讨这种关系的可能调节因素。方法对2009-2021年间在以色列最大的三级中心接受超声心动图评估的104315人进行回顾性研究。结果最终分析包括 32836 名患者,中位年龄为 56 岁(43-66 岁),其中女性 13547 人(41%)。中位 E/e' 为 8.3(6.8-10.3),9306 人(28%)的 E/e' 为 10。在中位数为 5.7(3.3-8.5)年的随访期间,有 2396 人(7.3%)死亡。E/e' >10与死亡率有关(调整后HR为1.16,95%CI为1.07-1.27,p<0.001)。年龄≤70 岁(HR 1.26,95%CI 1.12-1.42,p<0.001)、男性(HR 1.34,95%CI 1.19-1.49,p<0.001)、左心室质量正常(HR 1.13,95%CI 1.02-1.24,p=0.结论 E/e'升高与死亡率有关,特别是在年轻人、男性、左心室质量正常和肺动脉压力较低的人群中。这表明,在这些亚组中,E/e'升高可能是亚临床风险的标志。还需要进一步研究,以确定升高的 E/e'是否有助于心血管风险因素管理的共同决策。
{"title":"Modifiers of the Association between E/e' Ratio and Survival among Patients with No Apparent Structural or Functional Cardiac Abnormality","authors":"Yishay Wasserstrum ,&nbsp;Rami Gilead ,&nbsp;Sagit Ben-Zekry ,&nbsp;Efrat Mazor-Dray ,&nbsp;Anan Younis ,&nbsp;Amit Segev ,&nbsp;Elad Maor ,&nbsp;Rafael Kuperstein","doi":"10.1016/j.hjc.2024.01.005","DOIUrl":"10.1016/j.hjc.2024.01.005","url":null,"abstract":"<div><h3>Background</h3><div>The ratio between early mitral flow wave to early diastolic mitral annulus velocity (E/e’ ratio) varies according to age and sex and is associated with mortality in heart failure. We sought to describe the association between E/e’ and mortality in patients with no apparent structural or functional cardiac abnormality and explore possible modifiers of this association.</div></div><div><h3>Methods</h3><div>A retrospective study of 104,315 patients who underwent echocardiographic evaluation during 2009-2021 in the largest tertiary center in Israel. Patients with cancer, ventricular dysfunction, significant valvular or structural heart disease, or evidence of pulmonary hypertension were excluded.</div></div><div><h3>Results</h3><div>The final analysis included 32,836 patients with a median age of 56 (43-66) years, and 13,547 (41%) were female. The median E/e’ was 8.3 (6.8-10.3), and 9,306 (28%) had an E/e’ &gt;10. During a median follow-up of 5.7 (3.3-8.5) years, 2,396 (7.3%) individuals died. E/e’ &gt;10 was associated with mortality (adjusted hazard ratio [HR] 1.16, 95% confidence interval [CI] 1.07-1.27, p&lt;0.001). The mortality risk associated with E/e’ &gt;10 was significantly higher in those aged ≤70 (HR 1.26, 95% CI 1.12-1.42, p&lt;0.001), males (HR 1.34, 95% CI 1.19-1.49, p&lt;0.001), a normal left ventricular mass (HR 1.13, 95% CI 1.02-1.24, p = 0.017), and pulmonary artery pressure &lt;30 mmHg (HR 1.18, 95% CI 1.06-1.30, p = 0.003).</div></div><div><h3>Conclusion</h3><div>An elevated E/e’ is associated with mortality, specifically in younger individuals, males, and those with a normal left ventricular mass and lower pulmonary artery pressure. This suggests that an elevated E/e’ might be a marker of subclinical risk in these subgroups. Further studies are needed to identify whether an elevated E/e' is useful in shared decision-making regarding the management of cardiovascular risk factors.</div></div>","PeriodicalId":55062,"journal":{"name":"Hellenic Journal of Cardiology","volume":"83 ","pages":"Pages 20-27"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139551739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Causality between Gut Microbiota and Hypertension and Hypertension-related Complications: A Bidirectional Two-Sample Mendelian Randomization Analysis 肠道微生物群与高血压及高血压相关并发症之间的因果关系:双向双样本孟德尔随机分析
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-01 DOI: 10.1016/j.hjc.2024.02.002
Changhong Miao , Xinyi Xu , Shuoxuan Huang , Lingyi Kong , Zhiwei He , Yihan Wang , Kuang Chen , Lu Xiao

Background

Recent studies have highlighted a connection between gut microbiota and hypertension, yet the precise nature of this relationship remains unclear.

Objective

This research aims to analyze the causal link between gut microbiota and hypertension, along with associated complications, utilizing two-sample bidirectional Mendelian randomization (MR).

Materials and Methods

Summary data from genome-wide association studies (GWAS) meta-analyses, including gut microbiota GWAS data from 24 cohorts, and the latest GWAS data for hypertension-related conditions were acquired. Employing various MR methods, including Inverse-variance weighted (IVW), MR-Egger, Weighted Median, Simple Mode, and Weighted Mode, we investigated the association between gut microbiota and hypertension-related conditions. Sensitivity analyses were conducted for result stability, and reverse MR analysis assessed the potential for reverse causality.

Results

The Mendelian randomization analysis involving 199 microbial taxa and four phenotypes identified 46 microbial taxa with potential causal links to hypertension and its complications. Following Bonferroni correction, genus.Victivallis showed a robust causal relationship with hypertension (OR = 1.08, 95% CI = 1.04-1.12, P = 9.82e-5). This suggests an 8% increased risk of hypertension with each unit rise in genus.Victivallis abundance.

Conclusion

In conclusion, this study establishes a causal connection between gut microbiota and hypertension, along with common associated complications. The findings unveil potential targets and evidence for future hypertension and complication treatment through gut microbiota interventions, offering a novel avenue for therapeutic exploration.
背景:最近的研究强调了肠道微生物群与高血压之间的关系:最近的研究强调了肠道微生物群与高血压之间的联系,但这种关系的确切性质仍不清楚:本研究旨在利用双样本双向孟德尔随机化(MR)分析肠道微生物群与高血压及相关并发症之间的因果关系:获取全基因组关联研究(GWAS)荟萃分析的汇总数据,包括来自 24 个队列的肠道微生物群 GWAS 数据,以及最新的高血压相关疾病 GWAS 数据。我们采用各种 MR 方法,包括逆方差加权(IVW)、MR-Egger、加权中位数、简单模式和加权模式,研究了肠道微生物群与高血压相关疾病之间的关系。对结果的稳定性进行了敏感性分析,反向 MR 分析评估了反向因果关系的可能性:涉及 199 个微生物类群和 4 种表型的孟德尔随机分析确定了 46 个与高血压及其并发症有潜在因果关系的微生物类群。经过Bonferroni校正,Victivallis属与高血压有很强的因果关系(OR=1.08,95% CI=1.04-1.12,P=9.82e-5)。这表明,Victivallis 属丰度每增加一个单位,患高血压的风险就会增加 8%:总之,这项研究确定了肠道微生物群与高血压以及常见相关并发症之间的因果关系。研究结果揭示了未来通过肠道微生物群干预治疗高血压和并发症的潜在目标和证据,为治疗探索提供了一条新途径。
{"title":"The Causality between Gut Microbiota and Hypertension and Hypertension-related Complications: A Bidirectional Two-Sample Mendelian Randomization Analysis","authors":"Changhong Miao ,&nbsp;Xinyi Xu ,&nbsp;Shuoxuan Huang ,&nbsp;Lingyi Kong ,&nbsp;Zhiwei He ,&nbsp;Yihan Wang ,&nbsp;Kuang Chen ,&nbsp;Lu Xiao","doi":"10.1016/j.hjc.2024.02.002","DOIUrl":"10.1016/j.hjc.2024.02.002","url":null,"abstract":"<div><h3>Background</h3><div>Recent studies have highlighted a connection between gut microbiota and hypertension, yet the precise nature of this relationship remains unclear.</div></div><div><h3>Objective</h3><div>This research aims to analyze the causal link between gut microbiota and hypertension, along with associated complications, utilizing two-sample bidirectional Mendelian randomization (MR).</div></div><div><h3>Materials and Methods</h3><div>Summary data from genome-wide association studies (GWAS) meta-analyses, including gut microbiota GWAS data from 24 cohorts, and the latest GWAS data for hypertension-related conditions were acquired. Employing various MR methods, including Inverse-variance weighted (IVW), MR-Egger, Weighted Median, Simple Mode, and Weighted Mode, we investigated the association between gut microbiota and hypertension-related conditions. Sensitivity analyses were conducted for result stability, and reverse MR analysis assessed the potential for reverse causality.</div></div><div><h3>Results</h3><div>The Mendelian randomization analysis involving 199 microbial taxa and four phenotypes identified 46 microbial taxa with potential causal links to hypertension and its complications. Following Bonferroni correction, <em>genus.Victivallis</em> showed a robust causal relationship with hypertension (OR = 1.08, 95% CI = 1.04-1.12, P = 9.82e-5). This suggests an 8% increased risk of hypertension with each unit rise in <em>genus.Victivallis</em> abundance.</div></div><div><h3>Conclusion</h3><div>In conclusion, this study establishes a causal connection between gut microbiota and hypertension, along with common associated complications. The findings unveil potential targets and evidence for future hypertension and complication treatment through gut microbiota interventions, offering a novel avenue for therapeutic exploration.</div></div>","PeriodicalId":55062,"journal":{"name":"Hellenic Journal of Cardiology","volume":"83 ","pages":"Pages 38-50"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139713465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of cardiovascular risk factors in children aged 6–16 years and their evolution in early adulthood in a 10-year follow-up study 在一项为期 10 年的跟踪研究中,对 6-16 岁儿童的心血管风险因素及其在成年早期的演变情况进行了评估。
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-01 DOI: 10.1016/j.hjc.2024.02.006
Eleni Ntretsiou, Dimitris Benas, Paraskevi Trivilou, George Pavlidis, Ignatios Ikonomidis, Achilleas Attilakos, Efstathios Iliodromitis, Helen Triantafyllidi

Objective

Obesity and arterial hypertension (AH) in children represent well-recognized risk factors for cardiovascular (CV) events during adult life. We investigated any changes regarding several CV risk (CVR) factors in children after a 10-year follow-up period.

Methods

A cohort of 143 healthy children, elementary/high school students, 6–16 years old, was initially evaluated in 2010–2011 regarding CVR factors [obesity, blood pressure (BP), aortic stiffness (PWV), lipid profile] plus food habits/sports activity. At 10-years follow-up (2020–2021), 63/143 (44%) young adults were re-evaluated.

Results

Children with obesity (45%) had increased BP (p < 0.001) and a less favorable LDL-C/triglycerides profile (p = 0.001) compared to overweight/normoweight ones. In a 10-year follow-up, obesity and exercise improved (p < 0.001 and p = 0.005), systolic BP (SBP) (102 ± 13 vs. 118 ± 11 mmHg, p < 0.001) and PWV increased (6.1 ± 1 vs. 7.7 ± 1.1 m/sec, p < 0.001), LDL-C (96 ± 21 vs. 86 ± 24 mg/dl, p = 0.004) and HDL-C + (64 ± 18 vs. 55 ± 10 mg/dl, p < 0.001) decreased, triglycerides increased (62 ± 21 vs. 73 ± 34 mg/dl, p = 0.04), and food approached the western model of nutrition (less fish/fruits). In children/young adults, BMI was associated with age (Beta = 0.47, p < 0.001 and Beta = 0.36, p = 0.004), SBP (Beta = 0.46 and Beta = 0.52, p < 0.001), and LDL-C (Beta = 0.27 and Beta = 0.44, p < 0.001).

Conclusions

In children with obesity, increased BMI and waist circumference were related to SBP and a less favorable lipid profile. At the 10-year re-evaluation, obesity was partially improved, physical activity was increased, and SBP had reached the high-normal levels in a substantial number of young adults, while lipid profile was less favorable (for HDL-C/triglycerides) compared to baseline evaluation. Our results highlight the evolution of CVR factors from childhood to early adulthood.
目的:儿童肥胖和动脉高血压(AH)是公认的成年后心血管(CV)事件的风险因素。我们调查了儿童的几种心血管风险(CVR)因素在 10 年随访后的变化情况:方法:2010-2011 年,我们对 143 名 6-16 岁健康儿童(小学生/高中生)的心血管风险因素(肥胖、血压、主动脉僵硬度(脉搏波速度)、血脂)以及饮食习惯/体育活动进行了初步评估。在 10 年的随访中(2020-2021 年),63/143(44%)名青少年接受了重新评估:结果:肥胖症儿童(45%)的血压升高(p结论:肥胖症儿童的血压升高可能与饮食习惯有关:在肥胖儿童中,体重指数和腰围的增加与 SBP 和较差的血脂状况有关。在 10 年的重新评估中,肥胖情况得到了部分改善,体力活动增加,相当多的年轻成年人的 SBP 达到了正常水平,而血脂状况(高密度脂蛋白胆固醇/甘油三酯)与基线评估相比则较差。我们的研究结果突显了从儿童到成年早期心血管风险因素的演变。
{"title":"Evaluation of cardiovascular risk factors in children aged 6–16 years and their evolution in early adulthood in a 10-year follow-up study","authors":"Eleni Ntretsiou,&nbsp;Dimitris Benas,&nbsp;Paraskevi Trivilou,&nbsp;George Pavlidis,&nbsp;Ignatios Ikonomidis,&nbsp;Achilleas Attilakos,&nbsp;Efstathios Iliodromitis,&nbsp;Helen Triantafyllidi","doi":"10.1016/j.hjc.2024.02.006","DOIUrl":"10.1016/j.hjc.2024.02.006","url":null,"abstract":"<div><h3>Objective</h3><div>Obesity and arterial hypertension (AH) in children represent well-recognized risk factors for cardiovascular (CV) events during adult life. We investigated any changes regarding several CV risk (CVR) factors in children after a 10-year follow-up period.</div></div><div><h3>Methods</h3><div>A cohort of 143 healthy children, elementary/high school students, 6–16 years old, was initially evaluated in 2010–2011 regarding CVR factors [obesity, blood pressure (BP), aortic stiffness (PWV), lipid profile] plus food habits/sports activity. At 10-years follow-up (2020–2021), 63/143 (44%) young adults were re-evaluated.</div></div><div><h3>Results</h3><div>Children with obesity (45%) had increased BP (p &lt; 0.001) and a less favorable LDL-C/triglycerides profile (p = 0.001) compared to overweight/normoweight ones. In a 10-year follow-up, obesity and exercise improved (p &lt; 0.001 and p = 0.005), systolic BP (SBP) (102 ± 13 vs. 118 ± 11 mmHg, p &lt; 0.001) and PWV increased (6.1 ± 1 vs. 7.7 ± 1.1 m/sec, p &lt; 0.001), LDL-C (96 ± 21 vs. 86 ± 24 mg/dl, p = 0.004) and HDL-C + (64 ± 18 vs. 55 ± 10 mg/dl, p &lt; 0.001) decreased, triglycerides increased (62 ± 21 vs. 73 ± 34 mg/dl, p = 0.04), and food approached the western model of nutrition (less fish/fruits). In children/young adults, BMI was associated with age (Beta = 0.47, p &lt; 0.001 and Beta = 0.36, p = 0.004), SBP (Beta = 0.46 and Beta = 0.52, p &lt; 0.001), and LDL-C (Beta = 0.27 and Beta = 0.44, p &lt; 0.001).</div></div><div><h3>Conclusions</h3><div>In children with obesity, increased BMI and waist circumference were related to SBP and a less favorable lipid profile. At the 10-year re-evaluation, obesity was partially improved, physical activity was increased, and SBP had reached the high-normal levels in a substantial number of young adults, while lipid profile was less favorable (for HDL-C/triglycerides) compared to baseline evaluation. Our results highlight the evolution of CVR factors from childhood to early adulthood.</div></div>","PeriodicalId":55062,"journal":{"name":"Hellenic Journal of Cardiology","volume":"83 ","pages":"Pages 60-70"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139900910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of cardiovascular drugs on hyperglycemia and diabetes: a review of ‘unspoken' side effects 心血管药物对高血糖和糖尿病的影响:回顾 "难以启齿的副作用"。
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-01 DOI: 10.1016/j.hjc.2024.09.007
Wynne Widiarti , Pandit Bagus Tri Saputra , Cornelia Ghea Savitri , Johanes Nugroho Eko Putranto , Firas Farisi Alkaff

Aims

The increasing prevalence of cardiovascular diseases has led to the widespread use of cardiovascular drugs that can adversely impact glucose metabolism. This review focuses on the latest evidence on the potential of cardiovascular drugs to induce adverse glycemic effects but also the underlying mechanisms, prevention, and management strategies.

Materials and methods

A comprehensive literature search was conducted across scientific databases until May 25th, 2024.

Results

Certain cardiovascular drugs can induce hyperglycemia through multiple mechanisms, including altered the secretion and sensitivity of insulin through direct cytotoxic effects toward pancreatic beta cells and increased glucose secretion. Notably, diuretics, beta-blockers, calcium channel blockers, and statins have been associated with significant glycemic disturbances. The risk of hyperglycemia varies based on individual factors, drug dosages, and concurrent medications. These drug-induced hyperglycemic effects may sometimes reverse upon discontinuation of related medication. Effective management should include lifestyle modifications, the use of glucose-lowering medications, and opting for lower-risk cardiovascular drugs. Monitoring for hyperglycemia involves educating affected individuals and conducting regular blood glucose tests. Identifying at-risk individuals and implementing preventive measures are crucial for improving both cardiovascular and metabolic outcomes.

Conclusions

Certain cardiovascular drugs significantly contribute to hyperglycemia and diabetes mellitus through various mechanisms. Effective management includes identifying at-risk individuals, choosing lower-risk medications, and implementing monitoring and preventive strategies. Further research is needed to fully understand these mechanisms and develop targeted interventions to prevent and manage cardiovascular drug-induced hyperglycemia, thereby improving clinical outcomes.
目的:随着心血管疾病发病率的上升,可对糖代谢产生不良影响的心血管药物得到广泛使用。本综述重点关注心血管药物可能诱发不良血糖效应的最新证据,以及其潜在机制、预防和管理策略:在科学数据库中进行了全面的文献检索,直至 2024 年 5 月 25 日:某些心血管药物可通过多种机制诱发高血糖,包括通过对胰腺β细胞的直接细胞毒性作用改变胰岛素的分泌和敏感性,以及增加葡萄糖分泌。值得注意的是,利尿剂、β-受体阻滞剂、钙通道阻滞剂和他汀类药物与严重的血糖紊乱有关。高血糖的风险因个体因素、药物剂量和同时服用的药物而异。这些药物引起的高血糖效应有时会在停用相关药物后逆转。有效的管理应包括改变生活方式、使用降糖药物和选择风险较低的心血管药物。监测高血糖包括对患者进行教育和定期检测血糖。识别高危人群并采取预防措施对于改善心血管和代谢结果至关重要:结论:某些心血管药物通过各种机制导致高血糖和糖尿病。有效的管理包括识别高危人群、选择风险较低的药物以及实施监测和预防策略。要充分了解这些机制并制定有针对性的干预措施来预防和控制心血管药物引起的高血糖,从而改善临床疗效,还需要进一步的研究。
{"title":"The impact of cardiovascular drugs on hyperglycemia and diabetes: a review of ‘unspoken' side effects","authors":"Wynne Widiarti ,&nbsp;Pandit Bagus Tri Saputra ,&nbsp;Cornelia Ghea Savitri ,&nbsp;Johanes Nugroho Eko Putranto ,&nbsp;Firas Farisi Alkaff","doi":"10.1016/j.hjc.2024.09.007","DOIUrl":"10.1016/j.hjc.2024.09.007","url":null,"abstract":"<div><h3>Aims</h3><div>The increasing prevalence of cardiovascular diseases has led to the widespread use of cardiovascular drugs that can adversely impact glucose metabolism. This review focuses on the latest evidence on the potential of cardiovascular drugs to induce adverse glycemic effects but also the underlying mechanisms, prevention, and management strategies.</div></div><div><h3>Materials and methods</h3><div>A comprehensive literature search was conducted across scientific databases until May 25th, 2024.</div></div><div><h3>Results</h3><div>Certain cardiovascular drugs can induce hyperglycemia through multiple mechanisms, including altered the secretion and sensitivity of insulin through direct cytotoxic effects toward pancreatic beta cells and increased glucose secretion. Notably, diuretics, beta-blockers, calcium channel blockers, and statins have been associated with significant glycemic disturbances. The risk of hyperglycemia varies based on individual factors, drug dosages, and concurrent medications. These drug-induced hyperglycemic effects may sometimes reverse upon discontinuation of related medication. Effective management should include lifestyle modifications, the use of glucose-lowering medications, and opting for lower-risk cardiovascular drugs. Monitoring for hyperglycemia involves educating affected individuals and conducting regular blood glucose tests. Identifying at-risk individuals and implementing preventive measures are crucial for improving both cardiovascular and metabolic outcomes.</div></div><div><h3>Conclusions</h3><div>Certain cardiovascular drugs significantly contribute to hyperglycemia and diabetes mellitus through various mechanisms. Effective management includes identifying at-risk individuals, choosing lower-risk medications, and implementing monitoring and preventive strategies. Further research is needed to fully understand these mechanisms and develop targeted interventions to prevent and manage cardiovascular drug-induced hyperglycemia, thereby improving clinical outcomes.</div></div>","PeriodicalId":55062,"journal":{"name":"Hellenic Journal of Cardiology","volume":"83 ","pages":"Pages 71-77"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142407218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seasonal Variation in Sudden Cardiac Death: Insights from a Large United Kingdom Registry 心脏性猝死的季节性变化:来自英国大型登记处的启示
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-01 DOI: 10.1016/j.hjc.2024.01.006
Ioannis Panayiotides MD , Joseph Westaby BMBS, PhD, FRCPath , Elijah R. Behr MA, MBBS, FRCP , Michael Papadakis MBBS, MRCP, MD, MRCP , Sanjay Sharma BSc, MBChB, FRCP, MD , Gherardo Finocchiaro MD, PhD , Mary N. Sheppard MBBCH, BAO, BSc, MD, FRCPath, FRCPI

Background

Sudden cardiac death (SCD) is relatively common and may occur in apparently healthy individuals. The role of seasonal variation as a risk factor for SCD is poorly understood. The aim of this study was to investigate whether SCD exhibits a predilection for specific seasons.

Methods

We reviewed a database of 4751 cases of SCD (mean age 38 ± 17 years) referred to our Center for Cardiac Pathology at St George’s University of London between 2000 and 2018. Clinical information was obtained from referring coroners who were asked to complete a detailed questionnaire. All cases underwent macroscopic and histological evaluation of the heart, by expert cardiac pathologists.

Results

SCD was more common during winter (26%) and rarer during summer (24%), p = 0.161. Significant seasonal variation was not observed among cases of sudden arrhythmic death syndrome (SADS, 2910 cases) in which the heart is structurally normal. In contrast, a significant difference in seasonal distribution among decedents exhibiting cardiac structural abnormalities at the post-mortem examination (n = 1841) was observed. In this subgroup, SCDs occurred more frequently during winter (27 %) compared to summer (22%) (p = 0.007). In cases diagnosed with a myocardial disease (n = 1399), SCD was most common during the winter (27%) and least common during the summer (22%) (p = 0.027).

Conclusions

While SADS occurs throughout the year with no seasonal variation, SCD due to structural heart disease appears to be more common during the winter. Bio-meteorological factors may be potential triggers of SCD in individuals with an underlying structural cardiac abnormality.
背景心脏性猝死(SCD)比较常见,可能发生在表面健康的人身上。人们对季节性变化作为 SCD 风险因素的作用知之甚少。本研究的目的是调查 SCD 是否表现出对特定季节的偏爱。方法我们回顾了 2000 年至 2018 年期间转诊至伦敦圣乔治大学心脏病理中心的 4751 例 SCD(平均年龄为 38 ± 17 岁)的数据库。临床信息来自转诊的验尸官,他们被要求填写一份详细的调查问卷。所有病例均由心脏病理专家对心脏进行了宏观和组织学评估。结果SCD在冬季较常见(26%),夏季较罕见(24%),P= 0.161。在心脏结构正常的心律失常性猝死综合征(SADS,2910 例)病例中,未观察到明显的季节性变化。相比之下,在尸检时发现心脏结构异常的死者(1841 人)中,季节分布有明显差异。在这一分组中,冬季(27%)发生 SCD 的频率高于夏季(22%)(P=0.007)。结论虽然 SADS 全年发生,没有季节性变化,但结构性心脏病导致的 SCD 似乎在冬季更为常见。生物气象因素可能是潜在结构性心脏病患者发生 SCD 的潜在诱因。
{"title":"Seasonal Variation in Sudden Cardiac Death: Insights from a Large United Kingdom Registry","authors":"Ioannis Panayiotides MD ,&nbsp;Joseph Westaby BMBS, PhD, FRCPath ,&nbsp;Elijah R. Behr MA, MBBS, FRCP ,&nbsp;Michael Papadakis MBBS, MRCP, MD, MRCP ,&nbsp;Sanjay Sharma BSc, MBChB, FRCP, MD ,&nbsp;Gherardo Finocchiaro MD, PhD ,&nbsp;Mary N. Sheppard MBBCH, BAO, BSc, MD, FRCPath, FRCPI","doi":"10.1016/j.hjc.2024.01.006","DOIUrl":"10.1016/j.hjc.2024.01.006","url":null,"abstract":"<div><h3>Background</h3><div>Sudden cardiac death (SCD) is relatively common and may occur in apparently healthy individuals. The role of seasonal variation as a risk factor for SCD is poorly understood. The aim of this study was to investigate whether SCD exhibits a predilection for specific seasons.</div></div><div><h3>Methods</h3><div>We reviewed a database of 4751 cases of SCD (mean age 38 ± 17 years) referred to our Center for Cardiac Pathology at St George’s University of London between 2000 and 2018. Clinical information was obtained from referring coroners who were asked to complete a detailed questionnaire. All cases underwent macroscopic and histological evaluation of the heart, by expert cardiac pathologists.</div></div><div><h3>Results</h3><div>SCD was more common during winter (26%) and rarer during summer (24%), p = 0.161. Significant seasonal variation was not observed among cases of sudden arrhythmic death syndrome (SADS, 2910 cases) in which the heart is structurally normal. In contrast, a significant difference in seasonal distribution among decedents exhibiting cardiac structural abnormalities at the post-mortem examination (n = 1841) was observed. In this subgroup, SCDs occurred more frequently during winter (27 %) compared to summer (22%) (p = 0.007). In cases diagnosed with a myocardial disease (n = 1399), SCD was most common during the winter (27%) and least common during the summer (22%) (p = 0.027).</div></div><div><h3>Conclusions</h3><div>While SADS occurs throughout the year with no seasonal variation, SCD due to structural heart disease appears to be more common during the winter. Bio-meteorological factors may be potential triggers of SCD in individuals with an underlying structural cardiac abnormality.</div></div>","PeriodicalId":55062,"journal":{"name":"Hellenic Journal of Cardiology","volume":"83 ","pages":"Pages 3-9"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139495505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Twin circumflex arteries in a patient with lateral STEMI: Which is the culprit artery? 一名侧向 STEMI 患者的双环动脉。哪条是罪魁祸首动脉?
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-01 DOI: 10.1016/j.hjc.2024.06.012
Nikitas Katsillis, Antonios Dimopoulos, Sarantos Linardakis, Nikolaos Papakonstantinou, Nikolaos Patsourakos
{"title":"Twin circumflex arteries in a patient with lateral STEMI: Which is the culprit artery?","authors":"Nikitas Katsillis,&nbsp;Antonios Dimopoulos,&nbsp;Sarantos Linardakis,&nbsp;Nikolaos Papakonstantinou,&nbsp;Nikolaos Patsourakos","doi":"10.1016/j.hjc.2024.06.012","DOIUrl":"10.1016/j.hjc.2024.06.012","url":null,"abstract":"","PeriodicalId":55062,"journal":{"name":"Hellenic Journal of Cardiology","volume":"83 ","pages":"Pages 102-103"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141604575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sugars-related behavior of Greek University students and its association with different information sources 希腊大学生与糖有关的行为及其与不同信息来源的关联。
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-01 DOI: 10.1016/j.hjc.2024.07.009
Georgios Marakis , Maria G. Grammatikopoulou , Michail Chourdakis , Lamprini Kontopoulou , Eleni Vasara , Aikaterini Orfanogiannaki , Gorgias Garofalakis , Spyridoula Mila , Zoe Mousia , Emmanuella Magriplis , Antonis Zampelas
{"title":"Sugars-related behavior of Greek University students and its association with different information sources","authors":"Georgios Marakis ,&nbsp;Maria G. Grammatikopoulou ,&nbsp;Michail Chourdakis ,&nbsp;Lamprini Kontopoulou ,&nbsp;Eleni Vasara ,&nbsp;Aikaterini Orfanogiannaki ,&nbsp;Gorgias Garofalakis ,&nbsp;Spyridoula Mila ,&nbsp;Zoe Mousia ,&nbsp;Emmanuella Magriplis ,&nbsp;Antonis Zampelas","doi":"10.1016/j.hjc.2024.07.009","DOIUrl":"10.1016/j.hjc.2024.07.009","url":null,"abstract":"","PeriodicalId":55062,"journal":{"name":"Hellenic Journal of Cardiology","volume":"83 ","pages":"Pages 88-91"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-procedural Stratification by the Endothelial Function in Patients with Heart Failure Undergoing Atrial Fibrillation Ablation 根据内皮功能对接受心房颤动消融术的心力衰竭患者进行术前分层。
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-01 DOI: 10.1016/j.hjc.2024.02.003
Akihiro Oka MD , Yuya Sudo MD , Takeshi Morimoto MD, PhD, MPH , Ryu Tsushima MD , Masahiro Sogo MD , Masatomo Ozaki MD , Masahiko Takahashi MD , Keisuke Okawa MD, PhD

Background

Endothelial dysfunction (ED), a well-established risk marker of cardiovascular events, is associated with heart failure (HF) and atrial fibrillation (AF). Its relationship with cardiovascular events in patients with HF undergoing AF ablation remains unclear. We aimed to elucidate the association between ED and the outcomes after AF ablation in patients with HF.

Methods

This prospective cohort study included patients with HF who underwent an endothelial function assessment using the peripheral vascular reactive hyperemia index (RHI) before first-time AF ablation. We defined AF recurrence according to the following types: the conventional form (AF≥30 seconds) and persistent form (requiring cardioversion). An RHI<2.1 indicated ED. Those with and without ED were compared in terms of the 3-year incidence of AF recurrence and cardiovascular events after AF ablation.

Results

Among 421 patients with HF (69 ± 9 years and 38% females), 343 (81.5%) had ED. Although the incidence of the conventional form of AF recurrence was similar between the groups, that of the persistent form was significantly higher in the ED group (25.7% vs. 15.3%, log-rank P = 0.028). The ED group also had a significantly higher rate of cardiovascular events (14.8% vs. 3.6%, log-rank P = 0.028). Pre-procedural ED was identified as an independent predictor of a persistent form of AF recurrence (adjusted hazard ratio [HR] 2.31, 95% confidence interval [CI] 1.05–5.07, P = 0.037) and that of cardiovascular events (adjusted HR 4.21, 95% CI 1.02–17.5, P = 0.048), respectively.

Conclusions

The endothelial function assessment enabled the risk stratification of clinically problematic outcomes after AF ablation in patients with HF.
背景:内皮功能障碍(ED)是心血管事件的公认风险指标,与心力衰竭(HF)和心房颤动(AF)有关。在接受房颤消融术的高血压患者中,ED与心血管事件的关系仍不明确。我们旨在阐明 ED 与接受房颤消融术的高血压患者房颤消融术后的结果之间的关系:这项前瞻性队列研究纳入了在首次房颤消融术前使用外周血管反应性充血指数(RHI)进行内皮功能评估的房颤患者。我们根据以下类型定义房颤复发:常规形式(房颤≥30 秒)和持续形式(需要心脏复律)。结果:在 421 名房颤患者(69±9 岁,女性占 38%)中,343 人(81.5%)患有房颤。虽然两组常规房颤复发率相似,但 ED 组的持续性房颤复发率明显更高(25.7% 对 15.3%,对数秩 P=0.028)。ED 组的心血管事件发生率也明显更高(14.8% 对 3.6%,对数秩 P=0.028)。术前ED被确定为房颤持续复发(调整后危险比[HR]2.31,95%置信区间[CI]1.06-5.06,P=0.035)和心血管事件(调整后危险比4.26,95%置信区间[CI]1.03-17.7,P=0.028)的独立预测因素:内皮功能评估有助于对心房颤动患者房颤消融术后的临床问题结果进行风险分层。
{"title":"Pre-procedural Stratification by the Endothelial Function in Patients with Heart Failure Undergoing Atrial Fibrillation Ablation","authors":"Akihiro Oka MD ,&nbsp;Yuya Sudo MD ,&nbsp;Takeshi Morimoto MD, PhD, MPH ,&nbsp;Ryu Tsushima MD ,&nbsp;Masahiro Sogo MD ,&nbsp;Masatomo Ozaki MD ,&nbsp;Masahiko Takahashi MD ,&nbsp;Keisuke Okawa MD, PhD","doi":"10.1016/j.hjc.2024.02.003","DOIUrl":"10.1016/j.hjc.2024.02.003","url":null,"abstract":"<div><h3>Background</h3><div>Endothelial dysfunction (ED), a well-established risk marker of cardiovascular events, is associated with heart failure (HF) and atrial fibrillation (AF). Its relationship with cardiovascular events in patients with HF undergoing AF ablation remains unclear. We aimed to elucidate the association between ED and the outcomes after AF ablation in patients with HF.</div></div><div><h3>Methods</h3><div>This prospective cohort study included patients with HF who underwent an endothelial function assessment using the peripheral vascular reactive hyperemia index (RHI) before first-time AF ablation. We defined AF recurrence according to the following types: the conventional form (AF≥30 seconds) and persistent form (requiring cardioversion). An RHI&lt;2.1 indicated ED. Those with and without ED were compared in terms of the 3-year incidence of AF recurrence and cardiovascular events after AF ablation.</div></div><div><h3>Results</h3><div>Among 421 patients with HF (69 ± 9 years and 38% females), 343 (81.5%) had ED. Although the incidence of the conventional form of AF recurrence was similar between the groups, that of the persistent form was significantly higher in the ED group (25.7% vs. 15.3%, log-rank P = 0.028). The ED group also had a significantly higher rate of cardiovascular events (14.8% vs. 3.6%, log-rank P = 0.028). Pre-procedural ED was identified as an independent predictor of a persistent form of AF recurrence (adjusted hazard ratio [HR] 2.31, 95% confidence interval [CI] 1.05–5.07, P = 0.037) and that of cardiovascular events (adjusted HR 4.21, 95% CI 1.02–17.5, P = 0.048), respectively.</div></div><div><h3>Conclusions</h3><div>The endothelial function assessment enabled the risk stratification of clinically problematic outcomes after AF ablation in patients with HF.</div></div>","PeriodicalId":55062,"journal":{"name":"Hellenic Journal of Cardiology","volume":"83 ","pages":"Pages 51-59"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139718086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differential impact of diabetes mellitus on in-hospital mortality based on the circadian variation in acute myocardial infarction 基于急性心肌梗死昼夜节律变化的糖尿病对院内死亡率的不同影响。
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-01 DOI: 10.1016/j.hjc.2024.08.001
Kenichi Matsushita , Sunao Kojima , Kyoko Hirakawa , Noriaki Tabata , Miwa Ito , Kenshi Yamanaga , Koichiro Fujisue , Tadashi Hoshiyama , Shinsuke Hanatani , Daisuke Sueta , Hisanori Kanazawa , Seiji Takashio , Yuichiro Arima , Satoshi Araki , Hiroki Usuku , Satoru Suzuki , Eiichiro Yamamoto , Taishi Nakamura , Hirofumi Soejima , Koichi Kaikita , Kenichi Tsujita
{"title":"Differential impact of diabetes mellitus on in-hospital mortality based on the circadian variation in acute myocardial infarction","authors":"Kenichi Matsushita ,&nbsp;Sunao Kojima ,&nbsp;Kyoko Hirakawa ,&nbsp;Noriaki Tabata ,&nbsp;Miwa Ito ,&nbsp;Kenshi Yamanaga ,&nbsp;Koichiro Fujisue ,&nbsp;Tadashi Hoshiyama ,&nbsp;Shinsuke Hanatani ,&nbsp;Daisuke Sueta ,&nbsp;Hisanori Kanazawa ,&nbsp;Seiji Takashio ,&nbsp;Yuichiro Arima ,&nbsp;Satoshi Araki ,&nbsp;Hiroki Usuku ,&nbsp;Satoru Suzuki ,&nbsp;Eiichiro Yamamoto ,&nbsp;Taishi Nakamura ,&nbsp;Hirofumi Soejima ,&nbsp;Koichi Kaikita ,&nbsp;Kenichi Tsujita","doi":"10.1016/j.hjc.2024.08.001","DOIUrl":"10.1016/j.hjc.2024.08.001","url":null,"abstract":"","PeriodicalId":55062,"journal":{"name":"Hellenic Journal of Cardiology","volume":"83 ","pages":"Pages 92-95"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of cardiovascular events in giant cell arteritis: systematic review and meta-analysis 巨细胞动脉炎的心血管事件风险:系统回顾与元分析》。
IF 2.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-01 DOI: 10.1016/j.hjc.2024.10.008
Sawai Singh Rathore , Prakhyath Srikaram , Samyukta Gudena , Swetha Manoj , Sanjana Reddy Allam , Mohammad Abdalla Hatamleh , Naga Siva Naveen Chodisetti , Shifa Parvez Shaikh , Chiranjeevee Ramanathan Saravanan , Nathnael Abera Woldehana , Bijay Mukesh Jeswani

Objective

Giant cell arteritis (GCA) is a chronic inflammatory condition associated with a significantly increased risk of various cardiovascular and thromboembolic events. Existing studies suggest an increased risk of cardiovascular disease in GCA, but results vary. This meta-analysis aims to quantify the association between GCA and the risk of various cardiovascular outcomes, providing a comprehensive evaluation of the cardiovascular burden in patients with GCA.

Methods

A comprehensive literature search was carried out using several databases. Studies were included based on predefined eligibility criteria. Using random effect models, Mantel-Haenszel odds ratios and associated 95% confidence intervals were produced to report the overall effect size. Funnel plots, Egger regression tests, and Begg-Mazumdar's rank correlation test were used to assess publication bias. The endpoint included any cardiovascular events, myocardial infarction (MI), coronary artery disease (CAD), aortic aneurysm/dissection, peripheral artery disease (PAD), stroke, and venous thromboembolism.

Results

The meta-analysis included 14 studies with a combined sample size of 609,954 patients, where the mean age was 73.8 years and 72.2% were female. Patients with GCA had significantly higher odds of experiencing any cardiovascular event (OR = 1.81, 95% CI = 1.55–2.15), acute myocardial infarction (OR = 1.63, 95% CI = 1.34–1.97), coronary artery disease (OR = 1.51, 95% CI = 1.09–2.08), aortic aneurysm/dissection (OR = 1.95, 95% CI = 1.55–2.46), peripheral artery disease (OR = 2.02, 95% CI = 1.69–2.41), stroke (OR = 1.52, 95% CI = 1.25–1.84), venous thromboembolism (OR = 1.92, 95% CI = 1.73–2.12), deep vein thrombosis (OR = 2.09, 95% CI = 1.50–2.91) and pulmonary embolism (OR = 2.45, 95% CI = 1.38–4.36). The heterogeneity of the outcomes ranged from low to high across different analyses. No publication bias was evident in the analysis.

Conclusion

The meta-analysis highlights the critical need for vigilant cardiovascular monitoring and proactive management strategies in GCA patients. Further research is needed to identify specific factors that contribute to cardiovascular complications in these patients.
背景:巨细胞动脉炎(GCA)是一种慢性炎症,与各种心血管和血栓栓塞事件的风险显著增加有关。现有研究表明,GCA 患者罹患心血管疾病的风险增加,但结果各不相同。本荟萃分析旨在量化 GCA 与各种心血管疾病风险之间的关联,从而全面评估 GCA 患者的心血管负担:方法:使用多个数据库进行了全面的文献检索。方法:利用多个数据库进行了全面的文献检索,并根据预先确定的资格标准纳入了相关研究。使用随机效应模型、Mantel-Haenszel 赔率和相关的 95% 置信区间来报告总体效应大小。漏斗图、Egger回归检验和Begg-Mazumdar秩相关检验用于评估发表偏倚。终点包括任何心血管事件、心肌梗死(MI)、冠状动脉疾病(CAD)、主动脉瘤/夹层、外周动脉疾病(PAD)、中风和静脉血栓栓塞:荟萃分析包括 14 项研究,样本量共计 609,954 例患者,平均年龄为 73.8 岁,72.2% 为女性。GCA 患者发生任何心血管事件(OR = 1.81,95% CI = 1.55 至 2.15)、急性心肌梗死(OR = 1.63,95% CI = 1.34 至 1.97)、冠状动脉疾病(OR = 1.51,95% CI = 1.09 至 2.08)、主动脉瘤/夹层(OR = 1.95,95% CI = 1.55 to 2.46)、外周动脉疾病(OR = 2.02,95% CI = 1.69 to 2.41)、中风(OR = 1.52,95% CI = 1.25 to 1.84)、静脉血栓栓塞(OR = 1.92,95% CI = 1.73 to 2.12)、深静脉血栓(OR = 2.09,95% CI = 1.50 to 2.91)和肺栓塞(OR = 2.45,95% CI = 1.38 to 4.36)。不同分析结果的异质性从低到高不等。分析中未发现明显的发表偏倚:荟萃分析强调了对 GCA 患者进行警惕性心血管监测和采取积极管理策略的迫切需要。还需要进一步研究,以确定导致这些患者出现心血管并发症的具体因素。
{"title":"Risk of cardiovascular events in giant cell arteritis: systematic review and meta-analysis","authors":"Sawai Singh Rathore ,&nbsp;Prakhyath Srikaram ,&nbsp;Samyukta Gudena ,&nbsp;Swetha Manoj ,&nbsp;Sanjana Reddy Allam ,&nbsp;Mohammad Abdalla Hatamleh ,&nbsp;Naga Siva Naveen Chodisetti ,&nbsp;Shifa Parvez Shaikh ,&nbsp;Chiranjeevee Ramanathan Saravanan ,&nbsp;Nathnael Abera Woldehana ,&nbsp;Bijay Mukesh Jeswani","doi":"10.1016/j.hjc.2024.10.008","DOIUrl":"10.1016/j.hjc.2024.10.008","url":null,"abstract":"<div><h3>Objective</h3><div>Giant cell arteritis (GCA) is a chronic inflammatory condition associated with a significantly increased risk of various cardiovascular and thromboembolic events. Existing studies suggest an increased risk of cardiovascular disease in GCA, but results vary. This meta-analysis aims to quantify the association between GCA and the risk of various cardiovascular outcomes, providing a comprehensive evaluation of the cardiovascular burden in patients with GCA.</div></div><div><h3>Methods</h3><div>A comprehensive literature search was carried out using several databases. Studies were included based on predefined eligibility criteria. Using random effect models, Mantel-Haenszel odds ratios and associated 95% confidence intervals were produced to report the overall effect size. Funnel plots, Egger regression tests, and Begg-Mazumdar's rank correlation test were used to assess publication bias. The endpoint included any cardiovascular events, myocardial infarction (MI), coronary artery disease (CAD), aortic aneurysm/dissection, peripheral artery disease (PAD), stroke, and venous thromboembolism.</div></div><div><h3>Results</h3><div>The meta-analysis included 14 studies with a combined sample size of 609,954 patients, where the mean age was 73.8 years and 72.2% were female. Patients with GCA had significantly higher odds of experiencing any cardiovascular event (OR = 1.81, 95% CI = 1.55–2.15), acute myocardial infarction (OR = 1.63, 95% CI = 1.34–1.97), coronary artery disease (OR = 1.51, 95% CI = 1.09–2.08), aortic aneurysm/dissection (OR = 1.95, 95% CI = 1.55–2.46), peripheral artery disease (OR = 2.02, 95% CI = 1.69–2.41), stroke (OR = 1.52, 95% CI = 1.25–1.84), venous thromboembolism (OR = 1.92, 95% CI = 1.73–2.12), deep vein thrombosis (OR = 2.09, 95% CI = 1.50–2.91) and pulmonary embolism (OR = 2.45, 95% CI = 1.38–4.36). The heterogeneity of the outcomes ranged from low to high across different analyses. No publication bias was evident in the analysis.</div></div><div><h3>Conclusion</h3><div>The meta-analysis highlights the critical need for vigilant cardiovascular monitoring and proactive management strategies in GCA patients. Further research is needed to identify specific factors that contribute to cardiovascular complications in these patients.</div></div>","PeriodicalId":55062,"journal":{"name":"Hellenic Journal of Cardiology","volume":"83 ","pages":"Pages 78-87"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142630917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hellenic Journal of Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1